NCT00795873

Brief Summary

Post approval study measuring safety outcomes on the Ovatio CRT-D and SITUS OTW LV lead over 5 years.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,260

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

33 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 21, 2008

Completed
10 days until next milestone

Study Start

First participant enrolled

December 1, 2008

Completed
Last Updated

September 18, 2013

Status Verified

March 1, 2012

First QC Date

November 20, 2008

Last Update Submit

September 16, 2013

Conditions

Keywords

Heart failurecardiac resynchronization therapy

Outcome Measures

Primary Outcomes (1)

  • SITUS OTW LV lead complication free rate

    5 years

Secondary Outcomes (1)

  • System complication free rate

    6 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Heart failure patients needing CRT therapy

You may qualify if:

  • NYHA Class III/IV
  • Stable medical regimen
  • QRS greater than or equal to 130 ms
  • LVEF less than or equal to 35%

You may not qualify if:

  • VT of transient or reversible causes
  • Incessant VT
  • Currently implanted with a lead positioned through the coronary sinus (unless it is the SITUS OTW LV lead)
  • Cardiac revascularization or angioplasty within the last month
  • Heart failure due to correctable valve disease
  • Chronic, medially refractory AT
  • Enrolled in another clinical study that may confound the results of this study
  • Life expectancy less than 6 months
  • Inability to understand the purpose of the study or refusal to cooperate
  • Inability or refusal to provide informed consent
  • Unavailable for scheduled follow-up with the implanting practice
  • Sensitivity to 1 mg dexamethasone sodium phosphate
  • Less than 18 years of age
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (33)

Advanced Cardiac Specialists

Mesa, Arizona, 85201, United States

Location

Southwest Cardiovascular Associates

Mesa, Arizona, 85205, United States

Location

Cardiovascular Associates of Mesa

Mesa, Arizona, 85206, United States

Location

Cardiovascular Medical Group of Southern California

Beverly Hills, California, 90210, United States

Location

Center of Interventional Cardiology

Encino, California, 91436, United States

Location

Pacific Arrhythmia Service

La Mesa, California, 91942, United States

Location

Walter Kerwin, M.D., AMC

Los Angeles, California, 90048, United States

Location

Payam Robert Yashar, M.D. Inc.

Los Angeles, California, 90067, United States

Location

Valley Regional Arrhythmia Center

Tarzana, California, 91356, United States

Location

High Desert Heart Institute Medical Corp.

Victorville, California, 92395, United States

Location

Delaware Cardiovascular Associates

Wilmington, Delaware, 19958, United States

Location

Florida Institute for Cardiovascular Care

Hollywood, Florida, 33021, United States

Location

Electrophysiology Consultants of Florida

Miami Beach, Florida, 33140, United States

Location

Central Gerogia Heart Clinic

Macon, Georgia, 31201, United States

Location

Oschner Clinic Foundation

New Orleans, Louisiana, 70121, United States

Location

Primary Care Cardiology Research

Ayer, Massachusetts, 01432-1124, United States

Location

Internal Medicine & Cardiology Associates of SE New England, PC

Fall River, Massachusetts, 02720, United States

Location

Clipper Cardiovascular Associates

Newburyport, Massachusetts, 01950, United States

Location

Jackson Cardiology Associates, P.A.

Jackson, Mississippi, 39216, United States

Location

Atul Prakash, M.D.

Clifton, New Jersey, 07012, United States

Location

Cross County Cardiology

Edgewater, New Jersey, 07020, United States

Location

Hudson Heart Group, PC

Guttenberg, New Jersey, 07093, United States

Location

Cardiovascular Associates of Mountainside, PA

Mountainside, New Jersey, 07092, United States

Location

Joaquim J Correia, MD LLC

Newark, New Jersey, 07105, United States

Location

NJ Heart

Newark, New Jersey, 07105, United States

Location

Divagno Cardiology

Rochelle Park, New Jersey, 07662, United States

Location

The Heartcare Center

Saddle Brook, New Jersey, 07663, United States

Location

Clinical Cardiovascular Specialists

Columbus, Ohio, 43214, United States

Location

Toledo Clinic Inc.

Toledo, Ohio, 43623, United States

Location

Cardiovascular Consultants, Inc.

Tulsa, Oklahoma, 74136, United States

Location

Cardiac Consultants, PC

Lancaster, Pennsylvania, 17604-3200, United States

Location

Drexel University College of Medicine

Philadelphia, Pennsylvania, 19102, United States

Location

Midlands Cardiology Associates

Columbia, South Carolina, 29223, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2008

First Posted

November 21, 2008

Study Start

December 1, 2008

Last Updated

September 18, 2013

Record last verified: 2012-03

Locations